Evidence map›Paper›PMID 18542921›Full record

Trial reportIntensive care medicine2008

A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock.

Nicolas Boussekey, Arnaud Chiche, Karine Faure, Patrick Devos, Benoit Guery, Thibaud d'Escrivan, Hugues Georges, Olivier Leroy

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Intensive care medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 13 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 13 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Timing of kidney replacement therapy initiation for acute kidney injury.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Effect of High-Volume Hemofiltration in Critically Ill Patients: A Systematic Review and Meta-Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Pooled it
  3. Pooled it
  4. Timing of renal replacement therapy initiation for acute kidney injury.The Cochrane database of systematic reviews · 2018
    Pooled it
  5. Guideline
  6. Pooled it
  7. Pooled it
  8. High-volume haemofiltration for sepsis in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  9. Intensity of continuous renal replacement therapy for acute kidney injury.The Cochrane database of systematic reviews · 2016
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nicolas BoussekeyIntensive Care and Infectious Disease Unit, Tourcoing Hospital, 135, rue du Président Coty, BP 619, 59208, Tourcoing cedex, France. nboussekey@ch-tourcoing.fr
Arnaud Chiche
Karine Faure
Patrick Devos
Benoit Guery
Thibaud d'Escrivan
Hugues Georges
Olivier Leroy
Université de Lille · FRCentre Hospitalier de Tourcoing · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveHigh volume hemofiltration (HVHF) has shown potential benefits in septic animals and a few reports suggested a hemodynamic improvement in humans. However, randomized studies are still lacking. Our goal was to evaluate the hemodynamic effects of HVHF in septic shock patients with acute renal failure (ARF). DESIGN AND

settingProspective randomized study in an intensive care unit (ICU). PATIENTS: Twenty patients with septic shock and ARF.

interventionsPatients were randomized to either high volume hemofiltration [HVHF 65 ml/(kg h)] or low volume hemofiltration [LVHF 35 ml/(kg h). Vasopressor dose was adjusted to reach a mean arterial pressure (MAP) > 65 mmHg. MEASUREMENTS AND

resultsWe performed six hourly measurements of MAP, norepinephrine dose, PaO(2)/FiO(2) and lactate, and four daily urine output and logistic organ dysfunction (LOD) score. Baseline characteristics of the two groups were comparable on randomization. Mean norepinephrine dose decreased more rapidly after 24 h of HVHF treatment compared to LVHF treatment (P = 0.004) whereas lactate and PaO(2)/FiO(2) did not differ between the two treatment groups. During the 4-day follow-up, urine output was slightly increased in the HVHF group (P = 0.059) but the LOD score evolution was not different. Duration of mechanical ventilation, renal replacement therapy and ICU length of stay were also comparable. Survival on day 28 was not affected.

conclusionHVHF decreased vasopressor requirement and tended to increase urine output in septic shock patients with renal failure. However, a larger trial is required to confirm our results and perhaps to show a benefit in survival.

Indexed as

Hospital MortalityAcute Kidney InjuryAdultAgedAged, 80 and overAPACHEBlood PressureFemaleHemofiltrationHumansIntensive Care UnitsMaleMiddle AgedNorepinephrineRespiration, ArtificialShock, SepticNorepinephrineVasoconstrictor Agents

Identifiers

PMID18542921
OpenAlexW2127645629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.